Trial Profile
EVALUATION OF CARDIAC SAFETY, TOLERABILITY AND EFFICACY OF CUMULATIVE DOSES OF CHF5188 pMDI (FIXED COMBINATION BUDESONIDE/CARMOTEROL 200/1 microg) COMPARED TO SAME CUMULATIVE DOSES OF CARMOTEROL pMDI AND PLACEBO IN ASTHMATIC PATIENTS A MONOCENTER, RANDOMISED, DOUBLE-BLIND, 3-WAY, CROSS-OVER CLINICAL STUDY.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2012
Price :
$35
*
At a glance
- Drugs Budesonide/carmoterol (Primary) ; Carmoterol
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chiesi Farmaceutici
- 09 Jul 2011 New trial record